recana
(2)
Jeff Elkins Has Spent 30 Years Learning What Tiny Tools Must Get Right
Before Jeff Elkins became a repeat medtech CEO, he learned to scale products, read clinical data and worry about the expensive mistakes nobody else could see. His career is a practical study in how engineering judgment becomes company judgment.
InterVene, Inc.
InterVene, Inc. is a Redwood City, California vascular medical device company building catheter-based tools for severe venous disease. Born out of Stanford Biodesign, it first pioneered BlueLeaf, a non-implantable system that forms new vein valves from a patient's own tissue, then pivoted its lead product to Recana, an FDA-cleared thrombectomy catheter system that clears venous in-stent restenosis and native-vessel obstructions - a stubborn problem that leaves stented patients with debilitating complications and few good options.